The vaccine could represent a weapon for preventing Lyme, a bacterial infection carried by ticks that is diagnosed and ...
Emboline, Inc., a privately held medical technology company developing embolic protection solutions for structural heart procedures, today announced positive results from its pivotal PROTECT H2H ...
The Lakers finished a marvelous month of March by defeating yet another very good team in the Cavaliers thanks to another ...
PROTECT H2H is the first randomized IDE trial of an embolic protection device in TAVR to meet all primary and secondary safety and efficacy endpoints, representing a significant clinical and regulator ...
BACKGROUND: Medically tailored meals (MTM) have unanswered implementation questions. Providing MTM for a specific individual, ...
Seacoast letter writers push back on the wage gap, say Kittery council isn’t listening on Dennett Road, warn about guns at ...
Tristan H. Cockcroft takes a look at five pitchers who are likely to be on many a fantasy championship roster.
Welcome to another installment of This Week at FDA, your weekly source for updates – big and small – on FDA, drug, and medical device regulation and what we’re reading from around the web. This week, ...
The realistic fear is incremental normalisation of the use of artificial intelligence in warfare: as lethal discretion shifts ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results